Top

General Thoracic and Cardiovascular Surgery

Published in:

01-01-2014 | Current Topics Review Article

Current status and future perspectives of prosthetic valve selection for aortic valve replacement

Authors: Hiroshi Furukawa, Kazuo Tanemoto

Published in: General Thoracic and Cardiovascular Surgery | Issue 1/2014

Abstract

Aortic valve abnormality is the most frequent form of valvular heart disease. Notably, aortic stenosis in the elderly population has been increasingly common. Aortic valve replacement (AVR) using prosthetic valve has been still believed as a gold standard surgical intervention for various types of diseased aortic valve. The numerous reports and studies evaluating the clinical outcomes and durability of prosthesis were revealed, however, prosthesis selection for AVR is still debated. In twenty-first century, paradigm shift of prosthesis preference might be emerged from mechanical valves to bioprosthesis due to the development of the technology. Moreover, transcatheter aortic valve implantation accelerated among the worldwide trends. It could be developed having the potential to reduce the mortality and morbidity associated with high-risk traditional AVR. After the current guidelines for the management of patients with valvular heart disease, we should consider the valve choice in various patients’ profile setting. This review summarizes the current status of prosthesis selection and future perspectives of ideal aortic valve intervention, including minimal invasive care.

Dunning J, Gao H, Chambers J, Moat N, Murphy G, Pagano D, et al. Aortic valve surgery: marked increase in volume and significant decreases in mechanical valve use—an analysis of 41,227 patients over 5 years from the Society for Cardiothoracic Surgery in Great Britain and Ireland National database. J Thorac Cardiovasc Surg. 2011;142:776–82.PubMedCrossRef

Bonow RO, Carabello BA, Kanu C, de Leon AC, Faxon DP Jr, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2006;114:e84–231.PubMedCrossRef

Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease. The Joint Task Force on the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1–44.PubMedCrossRef

Kuwano H, Amano J, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2010. Gen Thorac Cardiovasc Surg. 2012;60:680–708.PubMedCrossRef

Wyss TR, Bigler M, Stalder M, Englberger L, Aymard T, Kadner A, et al. Absence of prosthesis-patient mismatch with the new generation of Edwards stented aortic bioprosthesis. Interact Cardiovasc Thorac Surg. 2010;10:884–8.PubMedCrossRef

Turillazzi E, Di Giammarco G, Neri M, Bello S, Riezzo I, Fineschi V. Coronary ostia obstruction after replacement of aortic valve prosthesis. Diagn Pathol. 2011;6:72–5.PubMedCentralPubMedCrossRef

Thomopoulou S, Sfirakis P, Spargias K. Angioplasty, stenting and thrombectomy to correct left main coronary stem obstruction by a bioprosthetic aortic valve. J Invasive Cardiol. 2008;20:E124–5.PubMed

Dell’Aquila AM, Schlarb D, Schneider SRB, Sindermann JR, Hoffmeier A, Kaleschke G, et al. Clinical and echocardiographic outcomes after implantation of the Trifecta aortic bioprosthesis: an initial single-centre experience. Interact Cardiovasc Thorac Surg. 2013;16:112–5.PubMedCrossRef

Yankah CA, Pasic M, Musci M, Stein J, Detschades C, Siniawski H, et al. Aortic valve replacement with the Mitroflow pericardial bioprosthesis: durability results up to 21 years. J Thorac Cardiovasc Surg. 2008;136:688–96.PubMedCrossRef

10.

Benhameid O, Jamieson WR, Castella M, Carrier M, Pomar JL, Germann E, et al. Carbomedics Mitroflow pericardial aortic bioprosthesis—performance in patients aged 60 years and older after 15 years. Thorac Cardiovasc Surg. 2008;56:195–9.PubMedCrossRef

11.

Riess FC, Cramer E, Hansen L, Schiffelers S, Wahl G, Wallrath J, et al. Clinical results of the Medtronic porcine bioprosthesis up to 13 years. Eur J Cardiothorac Surg. 2010;37:145–53.PubMedCrossRef

12.

Jamieson WRE, Riess FC, Raudkivi PJ, Metras J, Busse EFG, Goldstein J, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg. 2011;142:302–7.PubMedCrossRef

13.

Gerosa G, Tarzia V, Rizzoli G, Bottio T. Small aortic annulus: the hydrodynamic performances of 5 commercially available tissue valves. J Thorac Cardiovasc Surg. 2006;131:1058–64.PubMedCrossRef

14.

Taniguchi S, Noguchi M, Onohara D, Shibata R. Aortic valve replacement with 17-mm St. Jude Medical Regent prosthetic valves for a small calcified aortic annulus in elderly patients. Gen Thorac Cardiovasc Surg. 2010;58:506–10.PubMedCrossRef

15.

Okamura H, Yamaguchi A, Tanaka M, Naito K, Kimura N, Adachi H, et al. The 17-mm St. Jude Medical Regent valve is a valid option for patients with a small aortic annulus. Ann Thorac Surg. 2009;87:90–4.PubMedCrossRef

16.

Takaseya T, Kawara T, Tokunaga S, Kohno M, Oishi Y, Morita S, et al. Aortic valve replacement with 17-mm St. Jude Medical prostheses for a small aortic root in elderly patients. Ann Thorac Surg. 2007;83:2050–3.PubMedCrossRef

17.

Bernal JM, Lorca J, Prieto-Salceda D, Pulitani I, Pontón A, García I, et al. Performance at 10 years of the CarboMedics ‘Top-Hat’ valve. Postclamping time is a predictor of mortality. Eur J Cardiothorac Surg. 2006;29:144–9.PubMedCrossRef

18.

Roedler S, Czerny M, Neuhauser J, Zimpfer D, Gottardi R, Dunkler D, et al. Mechanical aortic valve prostheses in the small aortic root: top Hat versus standard CarboMedics aortic valve. Ann Thorac Surg. 2008;86:64–70.PubMedCrossRef

19.

Kobayashi Y, Fukushima Y, Hayase T, Kojima K, Endo G. Clinical outcome of aortic valve replacement with 16-mm ATS-Advanced Performance valve for small aortic annulus. Ann Thorac Surg. 2010;89:1195–9.PubMedCrossRef

20.

Nakamura Y, Nakano K, Tagusari O, Kataoka G, Seike Y, Domoto S, et al. An alternative option for elderly patients with a small aortic annulus: the 16 mm ATS valve. J Heart Valve Dis. 2009;18:691–7.PubMed

21.

Bottio T, Caprili L, Casarotto D, Gerosa G. Small aortic annulus: the hydrodynamic performances of 5 commercially available bileaflet mechanical valves. J Thorac Cardiovasc Surg. 2004;128:457–62.PubMedCrossRef

22.

Khoo JP, Davies JE, Ang KL, Galinanes M, Chin DT. Differences in performance of five types of aortic valve prostheses: haemodynamic assessment by dobutamine stress echocardiography. Heart. 2013;99:41–7.PubMedCrossRef

23.

Mohammadi S, Tchana-Sato V, Kalavrouziotis D, Voisine P, Doyle D, Baillot R, et al. Long-term clinical and echocardiographic follow-up of the Freestyle stentless aortic bioprosthesis. Circulation. 2012;126:S198–204.PubMedCrossRef

24.

Sepehripour AH, Harling L, Athanasiou T. What are the current results of sutureless valves in high-risk aortic valve disease patients? Interact Cardiovasc Thorac Surg. 2012;14:615–21.PubMedCrossRef

25.

Santarpino G, Pfeiffer S, Concistre G, Fischlein T. Perceval S aortic valve implantation in mini-invasive surgery: the simple sutureless solution. Interact Cardiovasc Thorac Surg. 2012;15:357–60.PubMedCrossRef

26.

Folliguet TA, Laborde F, Zannis K, Ghorayeb G, Haverich A, Shrestha M. Sutureless Perceval aortic valve replacement: results of two European centers. Ann Thorac Surg. 2012;93:1483–8.PubMedCrossRef

27.

Flameng W, Herregods MC, Hermans H, Van der Mieren G, Vercalsteren M, Poortmans G, et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg. 2011;142:1453–7.PubMedCrossRef

28.

Breitenbach I, Wimmer-Greinecker G, Bockeria LA, Sadowski J, Schmitz C, Kapelak B, et al. Sutureless aortic valve replacement with the Trilogy Aortic Valve System: multicenter experience. J Thorac Cardiovasc Surg. 2010;140:878–84.PubMedCrossRef

29.

Wendt D, Thielmann M, Buck T, Janosi RA, Bossert T, Pizanis N, et al. First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis. Eur J Cardiothorac Surg. 2008;33:542–7.PubMedCrossRef

30.

Aymard T, Kadner A, Walpoth N, Gober V, Englberger L, Stalder M, et al. Clinical experience with the second-generation 3f Enable sutureless aortic valve prosthesis. J Thorac Cardiovasc Surg. 2010;140:313–6.PubMedCrossRef

31.

Leon MB, Smith CR, Mack M, Miller C, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Eng J Med. 2010;363:1597–607.CrossRef

32.

Smith CR, Leon MB, Mack MJ, Miller C, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Eng J Med. 2011;364:2187–98.CrossRef

33.

Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med. 2012;366:1695–704.CrossRef

34.

Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686–95.PubMedCrossRef

35.

Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicenter, expanded evaluation registry 1-year following CE mark approval. Eurointervention. 2008;4:242–9.PubMedCrossRef

36.

Liang M, Devlin G, Pasupati S. The incidence of transcatheter aortic valve implantation-related heart block in self-expandable Medtronic CoreValve and balloon-expandable Edwards valves. J Invasive Cardiol. 2012;24:173–6.PubMed

37.

Walther T, Kempfert J, Borger MA, Fassl J, Falk V, Blumenstein J, et al. Human minimally invasive off-pump valve-in-a-valve implantation. Ann Thorac Surg. 2008;85:1072–3.PubMedCrossRef

38.

Wenaweser P, Buellesfeld L, Gerckens U, Grube E. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the Corevalve revalving system. Catheter Cardiovasc Interv. 2007;70:760–4.PubMedCrossRef

39.

Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, et al. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. J Am Coll Cardiol. 2012;60:1864–75.PubMedCrossRef

40.

Webb JG, Wood DA, Ye J, Gurvitch R, Masson JB, Rodes-Cabau J, et al. Transcatheter valve-in-valve implantation for failed bioprosthetic heart valves. Circulation. 2010;121:1848–57.PubMedCrossRef

41.

Tanaka K, Tajima K, Takami Y, Okada N, Terazawa S, Usui A, et al. Early and late outcomes of aortic valve replacement in dialysis patients. Ann Thorac Surg. 2010;89:65–71.PubMedCrossRef

42.

Chan V, Chen L, Mesana L, Mesana TG, Ruel M. Heart valve prosthesis selecting in patients with end-stage renal disease requiring dialysis: a systematic review and meta-analysis. Heart. 2011;97:2033–7.PubMedCrossRef

43.

Takemura H. Selection of artificial valve for the patients on hemodialysis. Gen Thorac Cardiovasc Surg 2013 (Epub ahead of print).

44.

Umezu K, Saito S, Yamazaki K, Kawai A, Kurosawa H. Cardiac valvular surgery in dialysis patients: comparison of surgical outcome for mechanical versus bioprosthetic valves. Gen Thorac Cardiovasc Surg. 2009;57:197–202.PubMedCrossRef

45.

Brinkman WT, Williams WH, Guyton RA, Jones EL, Craver JM. Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection. Ann Thorac Surg. 2002;74:37–42.PubMedCrossRef

46.

Fukui S, Yamamura M, Mitsuno M, Tanaka H, Ryomoto M, Miyamoto Y. Aortic valve prosthesis selection in dialysis patients based on the patient’s condition. J Artif Organs. 2012;15:162–7.PubMedCrossRef

47.

Kaplon RJ, Cosgrove DM III, Gillinov M, Lytle BW, Blackstone EH, Smedira NG. Cardiac valve replacement in patients on dialysis: influence of prosthesis on survival. Ann Thorac Surg. 2000;70:438–41.PubMedCrossRef

48.

Bianchi G, Solinas M, Bevilacqua S, Glauber M. Are bioprostheses associated with better outcome than mechanical valves in patients with chronic kidney disease requiring dialysis who undergo valve surgery? Interact Cardiovasc Thorac Surg. 2012;15:473–83.PubMedCrossRef

49.

Goodkin DA, Bragg-Gresham JL, Koenig KG, Wolfe RA, Akiba T, Andreucci VE, et al. Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the dialysis outcomes and practice patterns study (DOPPS). J Am Soc Nephrol. 2003;14:3270–7.PubMedCrossRef

50.

Rau S, Wessely M, Lange P, Kupatt C, Steinbeck G, Fischereder M, et al. Transcatheter aortic valve implantation in dialysis patients. Nephron Clin Pract. 2012;120:c86–90.PubMedCrossRef

51.

Ruel M, Chan V, Bedard P, Kulik A, Ressler L, Lam BK, et al. Very long-term survival implications of heart valve replacement with tissue versus mechanical prostheses in adults <60 years of age. Circulation. 2007;116:I-294–300.CrossRef

52.

Kulik A, Bedard P, Lam BK, Rubens FD, Hendry PJ, Masters RG, et al. Mechanical versus bioprosthetic valve replacement in middle-aged patients. Eur J Cardiothorac Surg. 2006;30:485–91.PubMedCrossRef

53.

Brown M, Schaff HV, Lahr BD, Mullany CJ, Sundt TM, Dearani JA, et al. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg. 2008;135:878–84.PubMedCrossRef

Title: Current status and future perspectives of prosthetic valve selection for aortic valve replacement
Authors: Hiroshi Furukawa
Kazuo Tanemoto
Publication date: 01-01-2014
Publisher: Springer Japan
Published in: General Thoracic and Cardiovascular Surgery / Issue 1/2014
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI: https://doi.org/10.1007/s11748-013-0262-0

2024 ASCO Annual Meeting

Springer Medicine

Current status and future perspectives of prosthetic valve selection for aortic valve replacement

Abstract

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Branch ligatures and blood aspiration for post-traumatic superficial temporal artery pseudoaneurysm: surgical technique

Memorial address for Togo Horiuchi (1924–2012)

Modified Konno procedure: surgical management of tunnel-like left ventricular outflow tract stenosis

Midterm outcomes of sutureless technique for postoperative pulmonary venous stenosis

Predictors of early and late outcome after total arch replacement for atherosclerotic aortic arch aneurysm

Mitral valve replacement versus annuloplasty for treating severe functional mitral regurgitation